Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Salicylic acid 60 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Salicylic acid 110 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
salicylsyragel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
bensoylperoxid 100 mikrogram/milligram, kutan gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
metronidazol, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Metronidazole 10 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 20 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
bensoylperoxid 2,5 % + klindamycin 1,2 %, gel för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
klindamycin 1,2 % / tretinoin 0,025 %, gel för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
Polynoxylin 100 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Adapalene 3 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Diclofenac sodium 30 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Ibuprofen 50 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely ketoprofen 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely piroxicam 5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Ibuprofen 100 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Fluocinolone acetonide 250 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Tretinoin 100 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 5 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 10 mg/mL cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
adapalen 1 mikrogram/milligram, kutan gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Desoximetasone 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
testosteron 1 %, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
Tretinoin 1 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
deoximetason 0,5 %, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
Fluocinonide 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
betametasondipropionat 0,05 %, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
Clobetasol propionate 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely ibuprofen 50 milligram/1 gram and levomenthol 30 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
testosteron 50 mg, gel 5 g, dospåse |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
terbinafinhydroklorid 1 %, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
Tretinoin 400 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 20 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Azelaic acid 150 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Dapsone 50 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Desonide 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Ketoconazole 20 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 100 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Coal tar 50 mg/g and pine tar 50 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Tazarotene 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Diclofenac diethylammonium 11.6 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Estradiol 600 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Testosterone 10 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
Terbinafine (as terbinafine hydrochloride) 10 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|